Bionano Genomics Inc.

NASDAQ: BNGO · Real-Time Price · USD
3.01
-0.20 (-6.23%)
At close: Aug 15, 2025, 3:01 PM

Bionano Genomics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Cash & Equivalents
3.63M 9.17M 8.79M 21.43M 15.76M 53.06M 34.57M 14.86M 4.1M 5.09M 28.17M 27.16M 24.05M 24.57M 140.74M 332.55M 362.06M
Short-Term Investments
14.61M 302K 14.16M 8.52M 37.01M 48.82M 29.01M 62.21M 91.7M 108.09M 152.02M 160.18M 192.42M 226.04M 185.33M n/a n/a
Long-Term Investments
n/a n/a n/a n/a 400K 400K 400K 400K n/a 400K n/a n/a n/a n/a n/a n/a n/a
Other Long-Term Assets
2.42M 3.15M 3.16M 6.29M 6.65M 7.43M 10.61M 3.4M 3.19M 2.81M 802K 841K 798K 749K 645K 270K 235K
Receivables
3.35M 4.77M 5.32M 6.25M 8.31M 9.66M 8.67M 7.61M 6.78M 7.02M 5.83M 4.85M 5.51M 4.93M 3M 2.84M 1.99M
Inventory
9.56M 11.12M 14.32M 19.48M 19.59M 22.89M 26.43M 32.45M 33.11M 29.76M 25.05M 20.59M 16.27M 12.39M 9.02M 4.89M 3.04M
Other Current Assets
13.78M 12.32M 4.39M 15.9M 4.95M 976K 5.86M 5.45M 6.86M 2.94M 7.13M 3.51M 4.11M 2.35M 3.96M 1.68M 3.17M
Total Current Assets
44.93M 39.49M 46.98M 60.57M 85.61M 140.12M 104.54M 122.58M 142.56M 157.3M 218.2M 216.29M 242.36M 272.41M 342.05M 341.96M 370.25M
Property-Plant & Equipment
22.7M 24.32M 26.18M 32.49M 33.6M 32.48M 30.99M 30.57M 29.77M 28.96M 25.65M 24.16M 23.38M 20.93M 8.55M 6.08M 5.81M
Goodwill & Intangibles
8.36M 9.7M 11.04M 30.02M 31.73M 33.97M 35.77M 114.84M 116.64M 118.43M 79.05M 80.26M 81.68M 83M 8.41M 8.49M 8.57M
Total Long-Term Assets
33.48M 37.18M 40.38M 68.8M 72.38M 74.29M 77.37M 148.81M 149.59M 150.2M 105.5M 105.26M 105.85M 104.69M 17.61M 14.84M 14.61M
Total Assets
78.41M 76.67M 87.36M 129.36M 158M 214.4M 181.9M 271.38M 292.15M 307.5M 323.7M 321.55M 348.21M 377.1M 359.66M 356.81M 384.86M
Account Payables
6.56M 6.96M 8.7M 8.73M 9.84M 10.38M 15.37M 11.91M 15.78M 12.53M 9.41M 7.7M 6.59M 9.7M 7.88M 3.75M 2.21M
Deferred Revenue
1.02M 1.13M n/a 1.15M 1.03M 783K 828K 995K 1.14M 871K 982K 1.25M 2.09M 684K 411K 445K 301K
Short-Term Debt
13.04M 17K 14.95M 19.36M 29.08M 69.8M 2.46M 2.29M n/a 2.54M 2.07M 2.05M n/a 1.77M n/a n/a n/a
Other Current Liabilities
2.43M 22.62M 2.47M 1.93M 13.82M 13.56M 18.17M 16.16M 16.4M 15.55M 16.07M 14.19M 4.99M 6.02M n/a n/a n/a
Total Current Liabilities
26.41M 37.34M 32.95M 37.17M 58.51M 100.03M 40.19M 33.5M 38.13M 35.88M 33.5M 27.91M 18.66M 21.84M 17.7M 10.73M 7.17M
Long-Term Debt
n/a n/a n/a n/a 6.33M 7.17M 7.68M n/a n/a 9.12M 8.32M 8.71M 9.09M 8.93M n/a n/a 14.87M
Other Long-Term Liabilities
n/a n/a n/a 5.77M 3.92M 3.71M 7.2M 14.57M 13.68M 3.85M -8.32M -8.71M 56K 136K 232K n/a n/a
Total Long-Term Liabilities
3.82M 3.95M 5.54M 11.85M 16.72M 18.22M 22.71M 23.13M 22.53M 22.22M 8.46M 8.91M 18.37M 18.14M 390K 213K 14.97M
Total Liabilities
30.23M 41.3M 38.49M 49.03M 75.22M 118.25M 62.91M 56.63M 60.66M 58.1M 41.96M 36.82M 37.03M 39.98M 18.09M 10.94M 22.14M
Total Debt
18.41M 6.93M 22.45M 27.57M 42.93M 87.95M 10.14M 10.66M 11.17M 11.67M 10.39M 10.76M 11.12M 10.7M n/a n/a 14.87M
Common Stock
n/a n/a 9K 7K 6K 5K 3K 3K 31K 30K 30K 29K 29K 29K 28K 28K 28K
Retained Earnings
-696.33M -693.23M -673.1M -628.85M -612.63M -581.21M -537.32M -424.75M -385.84M -348.71M -310.04M -278.23M -246.07M -216.12M -193.17M -172.42M -153.63M
Comprehensive Income
14K 27K 1.53M -3K -16K 23K -93K -310K -665K -1.12M -1.82M -1.92M -1.64M -539K -116K -0.00 -0.00
Shareholders Equity
48.19M 35.38M 48.87M 80.34M 82.77M 96.16M 119M 214.76M 231.49M 249.4M 281.74M 284.73M 311.19M 337.12M 341.56M 345.87M 362.72M
Total Investments
14.61M 302K 14.16M 8.52M 37.41M 49.22M 29.01M 62.21M 91.7M 108.09M 152.02M 160.18M 192.42M 226.04M 185.33M n/a n/a